About the Webinar

This webinar explores cutting-edge innovations in the development of alternative methods to animal testing, focusing on how emerging technologies like bioinformatics and bioprinting are revolutionizing preclinical safety and efficacy assessments. Key topics include the integration of in silico tools for predictive toxicology, the advancements in 3D bioprinting to create realistic tissue models, and how these technologies are driving a shift towards more ethical, sustainable, and accurate testing methodologies in the cosmetic and pharmaceutical industries.
 
 
​​​​​​​About the Speaker:

​​​​​​Bioprocess Engineer and Biotechnologist, holding a Master’s in Clinical Analysis from the University of São Paulo and a PhD in Chemical Engineering from Rensselaer Polytechnic Institute (USA). Currently serving as Principal Scientist at Grupo Boticário, where she leads the Alternative Methods Laboratory and the Preclinical Evaluation Team. Carolina work is at the forefront of innovation in 3D bioprinting, specializing in the development of reconstructed skin models and the application of alternative methods for the safety assessment and preclinical efficacy testing of products. She is also deeply involved in outreach initiatives, advocating for the adoption of non-animal testing approaches within the cosmetic industry.